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Abstract
Background: Selection of appropriate endogenous control is a critical step in gene expression analysis. The aim of
this study was to evaluate expression stability of four frequently used endogenous controls: b-actin,
glyceraldehyde-3-phosphate dehydrogenase, b2-microglobulin and RNA polymerase II polypeptide A in peripheral
blood mononuclear cells from war veterans with and without posttraumatic stress disorder (PTSD). The study was
designed as to identify suitable reference gene(s) for normalization of gene expression in peripheral blood
mononuclear cells in response to war trauma and/or PTSD.
Results: The variability in expression of the four endogenous controls was assessed by TaqMan Real-time RT-PCR
in peripheral blood mononuclear cells from: war veterans with current PTSD, those with lifetime PTSD, trauma
controls and healthy subjects. Expression stability was analyzed by GeNorm and NormFinder software packages,
and by direct comparison of Ct values. Both, GeNorm and NormFinder identified b-actin and glyceraldehyde-
3-phosphate dehydrogenase as a pair of genes with the lowest stability value.
Conclusions: The combination of b-actin and glyceraldehyde-3-phosphate dehydrogenase appeared to be the
most suitable reference for studying alterations in gene expression in peripheral blood mononuclear cells related
to vulnerability and resilience to PTSD, as well as to trauma-provoked developing of this disorder and recovery
from it. Using glyceraldehyde-3-phosphate dehydrogenase, b-actin and b2-microglobulin as individual endogenous
controls would provide satisfactory data, while RNA polymerase II polypeptide A could not be recommended.
Background
Post-traumatic stress disorder (PTSD) is the most com-
mon war-related psychiatric disorder that could occur
among war veterans and other people exposed to war-
zone stress. Several studies investigated gene expression
in peripheral blood mononuclear cells (PBMCs) from
PTSD patients using microarray analysis [1-3], and Real-
time PCR method [3,4]. Most of the data regarding gene
expression in psychiatric disorders were obtained from
studies carried out in PBMCs as easily available human
tissue. It was previously shown that transcriptional
changes in PBMCs reflect various pathological states
[5,6]. Moreover, gene expression changes in PBMCs
were paralleled by changes in neural tissue [7]. These
arguments support exploiting blood lymphocytes as a
source material for gene expression measurements in
studying psychiatric disorders when brain tissue biopsy
samples are unavailable [6-8].
Real-time PCR is a fast and convenient method for
quantification of gene transcription, and is suitable for
application both in research and clinical settings [9].
Compared to traditional methods for expression analy-
sis, such as Northern blot, in situ hybridization, RNase
protection assay and semi quantitative PCR, TaqMan
Real-time PCR is considered the most reliable, since it
does not include post PCR processing. It is simple, sen-
sitive and accurate, and particularly suitable when work-
ing with small amounts of starting material [10].
Therefore, Real-time PCR has been a method of choice
for investigation of gene expression in various diseases.
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many steps during the experimental procedure, from
sample preparation, handling and storage to RNA extrac-
tion and preserving, reverse transcription, specific amplifi-
cation etc [10-12]. Potential experimental inaccuracies
can be corrected by normalization of target gene expres-
sion to endogenous control as internal reference [13].
Therefore, the selection of proper endogenous control is
the first important step in mRNA quantification.
Housekeeping genes are widely used as endogenous
controls since their expression is assumed to be stable.
However, some studies imply the opposite. It appears
that expression of these so called “stable” genes can vary
in response to treatment, pathological or environmental
conditions, as well as between sexes, tissue types and
developmental stages [14-22]. Solving the problem of
selection of endogenous control seems to be crucial for
experimental design.
The aim of this study was to examine the relation of
war trauma and PTSD with the level of expression of
four frequently used endogenous controls in order to
identify the most stable reference gene for further investi-
gations. Toward that end the expression of b-actin (BA),
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), b2-
microglobulin (B2M) and RNA polymerase II polypeptide
A (PolR2A) in PBMCs from war veterans with current or
lifetime PTSD, without PTSD (trauma controls), and
from healthy non-traumatized subjects was studied by
the TaqMan Real-time PCR method.
Methods
Subjects
This study was performed on four groups of subjects:
(1) war veterans with current PTSD, (2) veterans with
PTSD in remission - lifetime PTSD, (3) individuals that
experienced war-related traumatic events but did not
develop PTSD - trauma controls, and (4) healthy non-
traumatized subjects.
Twenty eight subjects participated in the study (7 per
group). All participants were male and the groups were
matched by age. The traumatic experiences of the first
three groups were related to the recent wars in Balkan
region.
The inclusion criteria for the subjects with current or
lifetime PTSD included: (a) exposure to traumatic war
event(s); (b) current PTSD or lifetime PTSD as defined
by DSM-IV criteria and assessed by CAPS-DX and (c)
CAPS Criteria A-F satisfied, with the score of B+C+D
subtotals above 50.
Inclusion criteria for trauma controls were: (a) expo-
sure to traumatic war event(s), (b) no diagnosis of cur-
rent or lifetime PTSD as defined by the DSM-IV criteria
and assessed by the CAPS-DX and (c) CAPS Criteria
A-F not fulfilled, score of B+C+D subtotals below 30.
Healthy subjects have never experienced any severe
traumatic event and were free from any Axis I disorder.
Exclusion criteria for all groups were: (a) serious med-
ical illness, (b) current psychotic disorder, as defined by
DSM-IV criteria (except major depression), (c) current
psychoorganic syndrome, as defined by DSM-IV criteria,
(d) alcohol dependence or alcohol abuse within 6
months prior to the entry procedure, (e) substance
dependence or substance abuse within 6 months prior
the entry procedure, and (f) taking medications (list of
excluding medications from the groups of benzodiaze-
pines, antidepressants, neuroleptics, antipsychotics)
within at least 2 weeks prior to the entry procedure.
Structured Clinical Interview for DSM-IV, SCID-CV,
was used as a diagnostic tool for comorbidities.
PTSD patients were recruited from Association of
Veterans from Wars after 1990, the Association of Ex-
detained Persons, and war victims assessed or treated in
the NGO International Aid Network, Belgrade, Serbia.
Trauma control subjects were recruited from Associa-
tion of Veterans and from special army forces via Mili-
tary Medical Academy, Belgrade, Serbia.
Healthy non-traumatized subjects were recruited
through available social networks, National Trade
Union, and from general population with the assistance
of Strategic Marketing Agency. All subjects gave their
written informed consent for participating. All aspects
of the study were performed in accordance with the
ethical standards laid down in the 1964 Declaration of
Helsinki and the protocol was approved by the Ethical
Committee of the Clinical Center of Serbia.
Isolation of peripheral blood mononuclear cells
Peripheral blood was obtained by venipuncture. All sam-
ples were taken between 08:30 h and 09:30 h. The blood
was diluted with an equal volume of PBS (1.5 mM
KH2PO4, 6.5 mM Na2HPO4, 2.7 mM KCl, 0.14 M NaCl,
pH 7.2). PBMCs were prepared from whole blood by
Ficoll-Paque PLUS (GE Healthcare Amersham) density
gradient centrifugation. Mononuclear cells, recovered
from the plasma/Ficoll interface, were extensively
washed with PBS and resuspended in RPMI-1640
(Gibco) medium supplemented with 10% heat inacti-
vated fetal calf serum. After centrifugation cell pellets
were frozen in liquid nitrogen. Cell viability was assessed
by Trypan Blue exclusion, and always found to be more
than 95%.
RNA isolation and cDNA synthesis
Total mRNAs were isolated from previously frozen
PBMCs by RNeasy mini kit (Qiagen) according to the
manufacturer’s instruction. RNA was dissolved in
RNase-DNase free water (Eppendorf), RNase inhibitor
(Applied Biosystems) added and samples were frozen at
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determined spectrophotometricaly (OD 260/280 > 1.8
was considered satisfactory). Integrity of RNA was ana-
lyzed by 1% agarose gel electrophoresis. Total RNA was
treated with 10 U of RNase free DNase I (Fermentas)
according to the manufacturer’s protocol.
2 μg of RNA were converted to cDNA by reverse
transcription (RT) reactions in a 100 μlv o l u m ew i t h
random hexamer primers using High-Capacity cDNA
Archive Kit (Applied Biosystems) following the manu-
facturer’s instructions. The reactions were carried out
under RNase-free conditions at 25°C for 10 min and 37°
C for 2 h. Each RT reaction was accompanied by a no
RT control in which the reverse transcriptase was
replaced by DEPC water. The cDNA was stored at -80°
C until further use.
Real-time PCR
The expression of four commonly used endogenous
controls, BA, B2M, GAPDH and PolR2A, were evaluated
by TaqMan Real-time RT-PCR. Primers and probes
were obtained from Applied Biosystems Assay-
on-Demand Gene Expression Products: BA
(Hs99999903_m1), B2M (Hs99999907_m1), GAPDH
(Hs99999905_m1) and PolR2A (Hs00172187_m1). In
order to avoid non-specific product formation, selected
TaqMan MGB probes and primers were chosen as to
span across exon/exon boundaries. Amplicon lengths
were: 171 for BA, 75 for B2M, 122 for GAPDH and 61
bp for PolR2A.
Real-time PCR was performed using ABI Prism 7000
Sequence Detection System (Applied Biosystems) in a
total volume of 25 μl containing 1× TaqMan Universal
Master Mix with AmpErase UNG, 1× Assay Mix
(Applied Biosystems) and cDNA template (20 ng of
RNA converted to cDNA) at cycle conditions: 95°C for
10 min, followed by 40 cycles at 95°C for 15 s and 60°C
for 90 s. No template control was used in each run. All
reactions were run in triplicates.
PCR efficiencies for each assay were derived from
standard curves. Serial five-fold dilutions with at least
five measuring points of one randomly chosen cDNA
were made and amplified, and standard curves
constructed. Amplification efficiencies (E%) were calcu-
lated, using formula: E = (10
-1/slope - 1) × 100.
Data analysis
Data analysis was performed by direct comparison of Ct
values, followed by computer-assisted analysis using
software packages: GeNorm 3.5 http://medgen.ugent.be/
~jvdesomp/genorm[18] and Normfinder http://www.
mdl.dk/publicationsnormfinder.htm[23]. GeNorm makes
pairwise comparison between one endogenous control
and all other reference genes, in all samples. The soft-
ware ranks endogenous controls gene stability by aver-
age expression stability value (M). NormFinder is an
application for Microsoft Excel, which provides informa-
tion on intra- and inter-group variability, the informa-
tion regarding best endogenous control as well as best
combination of endogenous controls. More stable gene
expression is indicated by lower average expression sta-
bility values.
Results
The aim of this study was to identify the most stabile
reference gene(s) that could be used for the normaliza-
tion of quantification of mRNA expression in PBMCs
from war veterans with and without PTSD. Using Real-
time RT-PCR we evaluated the variability in expression
of four frequently used endogenous controls (BA, B2M,
GAPDH, PolR2A) in PBMCs from: current PTSD
patients, lifetime PTSD patients, trauma controls and
healthy subjects. To compare RNA transcription levels
of these genes between the four groups, we compared
Ct values directly, and also analyzed them using GeN-
orm and NormFinder.
The first step in our analysis was to test PCR effi-
ciency of four potential endogenous controls by amplify-
ing serial dilutions of one randomly chosen cDNA
sample. Amplification efficiencies of candidate endogen-
ous controls were calculated and presented in Table 1.
All r
2 values of the standard curves exceeded 0.998.
Next step was to check the effect of war trauma and/
or PTSD on expression stability of four possible endo-
genous controls. First, to explore the effect of the dis-
ease and/or trauma on mRNA level of four examined
Table 1 Gene symbol, molecular function and amplification efficiency of four candidate endogenous controls
Gene
Symbol
Gene Name Function Amplification efficiency E
(%)
BA b-Actin Cytoskeletal structural protein 96
B2M b2-Microglobulin b-Chain of major histocompatibility complex class I
molecule
91
GAPDH Glyceraldehyde-3-phosphate
dehydrogenase
Glycolytic enzyme 103
PolR2A RNA polymerase II
polypeptide A
DNA directed RNA polymerase activity 98
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jects were compared. Ct value is inversely correlated
with the amount of cDNA present in the reaction.
Expression profiles of B2M, BA, GAPDH and PolR2A
are presented in Figure 1. Abundance of the examined
endogenous controls was B2M>BA>GAPDH>PolR2A in
almost all subjects. Analysis of Ct values for each gene
showed inter-individual variations. Specifically, the range
of Ct values was 2.88 for PolR2A, 6.5 for B2M and 8 for
GAPDH and BA. Therefore PolR2A showed the lowest
v a r i a t i o ni nC tv a l u e s ,b u tB A ,G A P D Ha n dB 2 M
showed the same pattern of expression throughout all
individuals and conditions. Intra-assay variation was
<0.5% and inter-assay variation <1.5% for all assays.
As the next step, the differences between all possible
pairs of Ct values of potential endogenous controls (ΔCt
values) were compared between all subjects (Figure 2).
The rationale was that if ΔCt values of one pair of endo-
genous controls remain constant in all 28 subjects, it
implies either stable expression or co-regulation. Our
results showed that PolR2A-containing pairs had high
variability, and assuming no co-regulation, PolR2A
should be considered unsuitable endogenous control for
trauma-exposed and PTSD subjects. On the other hand,
pairs GAPDH vs B2M, BA vs B2M and GAPDH vs BA
showed less inter-individual variability, implying more
stable expression or possible co-regulation.
To verify these assumptions, gene expression stability
value (M) for B2M, BA, GAPDH and PolR2A in PBMCs
of the four groups of subjects was calculated by GeN-
orm and NormFinder softwares (Table 2). The basic
assumption of GeNorm method is that the ratio of two
perfect reference genes should be constant under differ-
ent experimental conditions. Stability value M is
calculated for each endogenous control, reflecting the
pair-wise variability between one and all the others. The
least stable candidate is excluded, and the M value recal-
culated. GeNorm identified BA and GAPDH as a pair of
genes with the lowest stability value, indicating this com-
bination of genes as the most stable one (Figure 3). The
individual M values are shown in Table 2. The analysis
revealed B2M as the most stable gene, followed by
GAPDH and BA, while PolR2A was the least stable one.
The GeNorm software also analyzed pair-wise variation
values between two sequential normalization factors
(geometric means of best reference genes). Normalization
factors were calculated by stepwise inclusion of extra, less
stable reference gene to determine how many reference
genes should be used. A large variation means that the
added gene has a significant effect on normalization fac-
tor and should be included for calculation. Vandesom-
pele et al [18] propose pair-wise variation of 0.15 as a
cut-off under which the inclusion of additional reference
gene is not required. The pair-wise variation upon nor-
malization with the two most stable genes in our study
and introduction of the third one was 0.246. This value
increased to 0.342 after addition of the fourth gene. Since
in this study only four reference genes were analyzed, the
c u t - o f fo f0 . 1 5w a sn o tc o n s i d e r e di nas t r i c ts e n s eb u t
rather as a guide for selection of reliable set of genes for
normalization. The four potential reference genes exam-
ined in our study belong to different functional classes,
which reduces the chance of co-regulation. Nevertheless,
we additionally analyzed exponentially transformed data
(2
-ΔCt) by the NormFinder software. NormFinder esti-
mates both inter- and intra-group variations, and com-
bines both of these in stability value. Similarly to
GeNorm, NormFinder pointed to BA and GAPDH
Figure 1 Expression profiles of four tested endogenous controls. Ct values of each gene and each individual subject are presented.
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of 0.006. As for the individual genes (Table 2), GAPDH
was identified as the most stable gene (stability value
0.008), while PolR2A as the least stable one (stability
value 0.039).
Since the NormFinder provides information on intra-
and inter-group variations, we have re-analyzed the
results across several subject group combinations.
NormFinder software was used to calculate stability
values, specify the best reference gene and the best com-
bination of two genes that can be used for future com-
parisons between various combinations of subject
groups (Table 3). B2M was identified as a suitable single
endogenous control for comparing changes in gene
expression between current PTSD patients and healthy
non-traumatized subjects; between current PTSD
patients and trauma controls, and between current
PTSD patients, trauma controls and healthy non-trau-
matized subjects (Table 3). GAPDH can be used as a
reference gene for gene expression studies designed to
compare gene expression in PBMCs from current and
Table 2 Expression stability values of GAPDH, BA, B2M
and PolR2A calculated by GeNorm and NormFinder
softwares
Gene GeNorm
Stability value (M)
NormFinder
Stability value (M)
GAPDH 0.898 0.008
BA 0.972 0.010
B2M 0.869 0.009
PolR2A 1.404 0.039
High expression stability corresponds to low stability value (M).
Figure 3 GeNorm analysis of BA, GAPDH, B2M and PolR2A. The
analysis includes a stepwise exclusion of the least stable
endogenous control. Endogenous controls are ranked in order of
their expression stability and presented at x-axis. Stability values (M)
are presented at y-axis. Low stability value (M) reflects greater
stability.
Figure 2 Comparison of ΔCt values of pairs of potential endogenous controls. ΔCt values were calculated for each of 28 subjects. Medians
are shown as lines, percentiles as boxes and ranges as whiskers.
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compare changes in gene expression between current
PTSD patients, lifetime PTSD patients and healthy sub-
jects, BA can be used as a single endogenous control
(Table 3). As the best combinations of two reference
genes that can be used for comparisons mentioned
above, the software pointed to B2M and GAPDH, and
to B2M and BA (Table 3).
Discussion
This study was designed as to identify suitable reference
gene(s) for normalization of gene expression in PBMCs
in response to war trauma and PTSD. The expression
stability of four possible endogenous controls was inves-
tigated in PBMCs from war veterans with current
PTSD, those with lifetime PTSD, trauma controls and
healthy non-traumatized subjects, in order to find the
most suitable reference gene(s) that can be used in the
future studies for comparing transcriptional changes
between these groups. Moreover, carefully defined cri-
teria for classification of participants into these four
groups enabled the selection of endogenous controls
that can also be used for comparisons between the var-
ious combinations of these groups, and consequently
allow more refined comparisons of gene expression that
might be used for future studying of vulnerability and
resilience to PTSD, as well as studying developing and
recovery from PTSD.
Selection of appropriate endogenous control is a critical
step in gene expression analysis, especially in situations
where differences in mRNA levels are small. In the present
study we analyzed the expression stability of four com-
monly used endogenous controls (BA, B2M, GAPDH and
PolR2A) and showed that combination of BA and
GAPDH can serve as a suitable normalizing factor for pur-
poses of studying changes in gene expression in PBMCs
related to war trauma and current or lifetime PTSD.
BA, GAPDH and B2M are frequently used endogen-
ous controls, although the issue of using these genes for
normalization is a constant matter of debate. BA is
ubiquitous cytoskeleton protein, GAPDH is important
glycolitic enzyme, and B2M is b-chain of major histo-
compatibility complex class I molecule. However, apart
from their basic cellular roles, these proteins also parti-
cipate in other cellular functions [24-26]. As a result,
previous studies pointed to the variability in expression
of these housekeeping genes between sexes, tissue types,
as well as in response to treatment and pathological or
environmental conditions [9,10,15-22]. On the other
hand, there is evidence favoring their use as appropriate
internal standards, either separately or in various combi-
nations, in a number of carefully defined conditions.
For example, GAPDH showed stable expression and
c o u l db eu s e da sar e f e r e n c eg e n ef o rg e n ee x p r e s s i o n
studies in human leukocytes [27], reticulocytes [28],
hepatocellular carcinoma [29], prostate cancer [30] and
heart tissue [31]. Also, GAPDH was one of the most
stable reference genes recommended as endogenous
control for investigation of chondroprotective agents in
human chondrocytes [32], as well as for comparing age-
related changes in gene expression in human skeletal
muscle [33].
BA was shown to be a suitable endogenous control for
gene expression studies in human neutrophils [34], leu-
kocytes [27] and prostate cancer [30], as well as for
comparing gene expression in prefrontal cortex of
chronic alcoholics and control subjects [35].
B2M, together with 18S rRNA, was validated as a refer-
ence gene for investigations in serum stimulated fibro-
blasts [20], and for examination of the effects of ionizing
radiation and chemical exposure on gene expression in
human lymphoblastoid cells [36]. It could also be used as
an endogenous control in studies of gene expression in
human neutrophils [34], skeletal muscle [33] and osteoar-
thritic articular cartilage [37], as well as in studies of
chondroprotective action of curcumin [32].
PolR2A is the largest subunit of RNA polymerase II
complex and the main enzyme in mRNA transcription.
The use of PolR2A as endogenous control in human tis-
sues and cell lines has been supported by several authors
Table 3 Expression stability values of the best reference gene and the best combination of two genes for between-
group comparisons.
Current PTSD
patients vs. trauma
controls
Current PTSD
vs. healthy
subjects
Current PTSD, trauma
controls vs. healthy
subjects
Current PTSD, lifetime
PTSD vs. trauma
controls
Current PTSD, lifetime
PTSD vs. healthy
subjects
Best gene B2M B2M B2M BA GAPDH
Stability value (M) 0.011 0.037 0.008 0.007 0.029
Best combination of two
genes
B2M and BA B2M and GAPDH B2M and GAPDH B2M and BA B2M and GAPDH
Stability value for best
combination of two
genes (M)
0.009 0.041 0.007 0.006 0.029
Stability values were calculated by NormFinder software. High expression stability corresponds to low stability value (M).
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was a suitable reference gene for a broad range of human
tissues. It was also shown to be one of the most stable
genes for normalization of gene expression in non-small
cell lung cancer [39], in motor cortex of alcoholics and
control subjects [35], and in human skeletal muscle [33].
However, PolR2A did not perform well in our study and
both NormFinder and GeNorm identified it as the most
variable among the examined genes.
In the present study, direct comparison of Ct values
showed marked inter-individual variations for all four
validated genes. BA, GAPDH and B2M showed similar
pattern of expression throughout all individuals and
conditions, whereas the lowest range of Ct values for
PolR2A was observed (~3 Ct). However, when the
expression stability of BA, B2M, GAPDH and PolR2A in
PBMCs of PTSD patients and control subjects was eval-
uated by GeNorm and NormFinder software packages,
PolR2A was identified as the most unstable gene. BA,
GAPDH and B2M performed well, although the ranking
order differed between these two softwares. NormFinder
identified GAPDH, while GeNorm identified B2M as a
suitable single endogenous control with the most stable
expression. These discrepancies are caused by the differ-
ences between the approaches. Simple comparison of Ct
values reveals “overall expression variation” without tak-
ing into the consideration systematic inter-group varia-
tion which is critical and could lead to an incorrect
interpretation of the results. The NormFinder top ranks
the candidates with minimal estimated intra- and inter-
group variation, in contrast to the pairwise comparison
approach (GeNorm), which tends to select those genes
with the highest degree of similarity of the expression
profile across the sample set. The latter approach
implies that the candidates with minimal expression var-
iation do not necessarily become top ranked. Therefore,
a situation in which the sample set consists of four sam-
ple subgroups, and all of the candidates but one
(PolR2A) show some variation in and between the
groups, like in this case, the candidate with the lowest
overall variation would be excluded early on in the pair-
wise comparison approach. Contrary to this, NormFin-
der would present such a gene with the smallest
stability value of all candidates if it had shown no or
small inter-group (particularly) and intra-group varia-
tion. However, “overall expression variation” of PolR2A
is mostly due to inter-group variation and NormFinder
identified PolR2A as the most unstable gene, as well.
Taken together, comparison of Ct values only is not
enough because this approach does not take into con-
sideration intra- and inter-group variation and when
introducing a larger set of samples, the range of Ct var-
iation could dramatically change. Pair-wise comparison
approach (GeNorm) is regarded as the authoritative
method for the analysis of potential endogenous con-
trols but it ranks genes according to the similarity of
their expression profiles, rather than minimal variation.
NormFinder, with its account of sample groups and its
direct estimation of expression variation, provides even
more precise and robust measure of gene expression
stability and most importantly candidate co-regulation
does not significantly affect the approach.
Therefore, it is strongly urged to introduce more
approaches in validation of endogenous controls and the
best situation would be when two of them reveal the
same results. Both software packages pointed to BA and
GAPDH as the best combination of endogenous con-
trols that can be used for normalization of gene expres-
sion in PBMCs from patients with current or lifetime
PTSD, trauma controls and healthy subjects. In addition,
we have re-analyzed results using NormFinder software
in order to provide endogenous controls that can be
used for particular comparisons between some of the
examined groups of subjects. It appeared that B2M, BA
and GAPDH, individually or in combinations (specified
in Table 3) can also be used in future studies on
changes in gene expression related to vulnerability,
recovery and resilience to PTSD.
The advantage of using multiple reference genes com-
bination for normalization instead of GAPDH, B2M or
BA alone is not clearly evident in this study since the
comparison of the stability values of individual endogen-
ous controls and stability values for best combination of
two genes have not revealed significant differences.
However, introducing larger set of samples might make
a difference and so it is strongly recommended to use
more than one reference gene for normalization [18] as
a way to increase the accuracy of the results and to
reach the sensitivity needed for detection of subtle
changes in a target gene expression.
To date only two studies used Real-time RT-PCR to
examine gene expression in PBMCs from PTSD patients
and healthy subjects [3,4]. Namely, to normalize p11
and GR expression in PBMCs from healthy non-trauma-
tized subjects and patients with PTSD, major depressive
disorder, bipolar disorder or schizophrenia, Su and cow-
orkers [4] used BA as a reference gene. Yehuda and
coworkers [3] chose reference gene from BA, GAPDH,
B2M and ribosomal protein large P0, to normalize the
amount of FKBP5 mRNA in PBMCs from current
PTSD and non PTSD subjects exposed to 9/11 terrorist
attack. In concert with the published data, the results
presented herein show that BA, GAPDH and B2M
could be used either alone or in a combination, for nor-
malization of gene expression in PBMCs from current
and lifetime PTSD patients, trauma controls and healthy
subjects. The assumption that exposure to war trauma,
current PTSD and lifetime PTSD may be related to
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mined the way of classification of the subjects partici-
pating in this study. The applied classification into the
four groups enabled us to select internal reference genes
for future studies on gene expression in PBMCs from
individuals exposed to war trauma who were susceptible
or resilient to PTSD, as well as from those with the cur-
rent disorder and those who recovered.
As a limitation of our study, we should mention that
only four commonly used endogenous controls were
examined. We selected genes which belong to distinct
biological pathways with the intention to avoid possible
co-regulation. In addition, only male subjects partici-
pated in our study in order to avoid possible differences
between sexes.
Conclusion
In conclusion, the most reliable and precise quantifica-
tion of gene expression in PBMCs from war veterans
with and without PTSD could be achieved by normaliza-
tion to a combination of two reference genes: GAPDH
and BA. Using GAPDH, BA and B2M as individual
endogenous controls would provide satisfactory data,
while PolR2A could not be recommended.
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